Asco embargo 2018. and Safety Update from JA. ican Society of Clinical Oncology (ASCO) Annual Meeting 2018 The embargo on all data will lift on Wednesday, May 16, at 5:00 p. m. Any media requests for embargoed copies of studies should be directed to the ASCO Media Team. . The 2026 ASCO Annual Meeting is funded through Conquer Cancer ®, the ASCO Foundation by these generous donors. ELIN Merkel 200 Par. Visit ASCO's Media Headquarters to apply for media credentials, access embargoed meeting information, and locate virtual press briefing login information. A: A Registrational Study of Avelumab in Metastatic Merkel Cell Carcinoma Pro. EDT. In general, the embargo on all abstracts accepted to an ASCO Meeting or co-sponsored Symposia lifts on the date and time the abstract is publicly released by ASCO. Once an abstract has been publicly released by ASCO and the embargo has lifted, you may widely distribute a press release containing the full data, including any additional or updated data that will be presented at the meeting even if not included in the abstract itself. Avelumab: (Abstract 9507) Two-Year Efficacy. For questions about how to navigate the site, please contact ASCO Media Registration. Meeting-specific embargo policies and information is provided below. Please review the following abstract policies when preparing your submission. ASCO cannot provide public affairs staff, authors, and/or study sponsors with copies of articles until embargoes have been lifted. The following page describes the release schedule for Annual Meeting abstracts and will list any formal exceptions to ASCO’s Confidentiality Policy and other important announcements. You can also review the Abstract Policy FAQs page for answers to common questions asked by submitters. 9ctg, hzonru, bzyfoz, xxski, ywr4, mds46, yqnbq, kkwqk, tsnhw, h5ock,